2840-74-6 Usage
General Description
αα-dimethyl-δ-phenyl-n-valeric acid is a chemical compound with the molecular formula C14H22O2. It is a fatty acid derivative with a branched structure, and it contains a valeric acid backbone with a phenyl group and two methyl groups attached to the carbon atoms. αα-dimethyl-δ-phenyl-n-valeric acid is commonly used as a precursor in the synthesis of pharmaceuticals, flavors, and fragrances. It is also known for its potential biological activities, including anti-inflammatory and analgesic properties. Additionally, αα-dimethyl-δ-phenyl-n-valeric acid has been studied for its potential use in the treatment of epilepsy and neurodegenerative diseases. Overall, this chemical compound has various applications and potential benefits in the fields of medicine and organic chemistry.
Check Digit Verification of cas no
The CAS Registry Mumber 2840-74-6 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 2,8,4 and 0 respectively; the second part has 2 digits, 7 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 2840-74:
(6*2)+(5*8)+(4*4)+(3*0)+(2*7)+(1*4)=86
86 % 10 = 6
So 2840-74-6 is a valid CAS Registry Number.
2840-74-6Relevant articles and documents
Nickel(0)/NaHMDS adduct-mediated intramolecular alkylation of unactivated arenes via a homolytic aromatic substitution mechanism
Beaulieu, Louis-Philippe B.,Roman, Daniela Sustac,Vallee, Frederic,Charette, Andre B.
supporting information; experimental part, p. 8249 - 8251 (2012/09/07)
A variety of polycycles can be synthesized via an intramolecular alkylation cyclization promoted by Ni(PPh3)4 and NaHMDS. Mechanistic investigations support the catalytic nature of Ni0 in the course of TEMPO scavenging experiments and its association with the substrate and NaHMDS to form an adduct by DOSY NMR.
Quaternary ammonium antiarrhythmic drugs
-
, (2008/06/13)
Quaternary ammonium salts of certain phenylbutylamines are useful antiarrhythmic drugs. A method for treating arrhythmia and prolonging the action potential of cardiac tissue is provided. Pharmaceutical formulations containing such quaternary ammonium salts are disclosed.
